(Q51629651)

English

No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetes.

scientific article published in May 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

Scott RS

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

Donnelly T

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

publication date

1 May 1987

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

Diabetes Research and Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

175-178

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2887%2980024-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of co-ingestion of fat on the metabolic responses to slowly and rapidly absorbed carbohydrates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2887%2980024-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2887%2980024-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2887%2980024-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gliclazide on long-term therapy increases insulin response to glucose of type II diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2887%2980024-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8227(87)80024-4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3595434

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51629651&oldid=1569860648"